Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M202Revenue $M0Net Margin (%)0Z-Score4.1
Enterprise Value $M145EPS $-0.6Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %0Quick Ratio17.3Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio17.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-22.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-27.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M46.5ROI % (ttm)-69.7Gross Margin Increase y-yN

Gurus Latest Trades with CNDO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CNDOGeorge Soros 2014-09-30 Sold Out $1.48 - $2.16
($1.77)
$ 4.3459%Sold Out0
CNDOGeorge Soros 2014-06-30 Buy $1.55 - $2.02
($1.76)
$ 4.3459%New holding29,279
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CNDO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CNDO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lu LucyCFO 2014-12-01Buy5,000$1.45177.93 view
ROSENWALD LINDSAY A MDPresident and CEO, 10% Owner 2014-12-01Buy974$1.45177.93 view
ROSENWALD LINDSAY A MDPresident and CEO, 10% Owner 2014-11-06Buy150,000$1.61150.31 view
Hoenlein MalcolmDirector 2014-11-06Buy25,000$1.61150.31 view
WEISS MICHAEL SExec. VC - Strategic Dev., 10% Owner 2014-11-06Buy1,000,000$1.61150.31 view
Lu LucyCFO 2014-06-02Buy5,000$1.37194.16 view
HORGAN KEVINFormer Chief Medical Officer 2014-04-22Sell47,566$1.89113.23 view
HORGAN KEVINFormer Chief Medical Officer 2014-04-21Sell19,000$1.81122.65 view
HORGAN KEVINFormer Chief Medical Officer 2014-04-17Sell101$1.85117.84 view
Lu LucyCFO 2013-12-04Buy1,107$1.39189.93 view

Press Releases about CNDO :

    Quarterly/Annual Reports about CNDO:

    News about CNDO:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight Jul 28 2013 
    Weekly CFO Buys Highlight Jul 21 2013 
    Weekly CFO Buys Highlight Jun 11 2013 
    Weekly CEO Buys Highlight: CNDO Jan 21 2013 
    Coronado Biosciences New CEO Makes First Buy of the Year, Worth $114K Jan 16 2013 
    Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO Jun 30 2012 
    Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO Jun 30 2012 


    More From Other Websites
    Coronado Biosciences Forms New Subsidiary, DiaVax Biosciences, to Develop Novel Immunotherapies for... Apr 02 2015
    Coronado Biosciences Forms New Subsidiary, DiaVax Biosciences, to Develop Novel Immunotherapies for... Apr 02 2015
    Coronado Biosciences upgraded by MLV & Co Mar 31 2015
    Coronado Biosciences, Inc. (CNDO) in Focus: Stock Jumps 8.6% - Tale of the Tape Mar 25 2015
    CORONADO BIOSCIENCES INC Financials Mar 21 2015
    Stocks sold off on Thursday — except for the one sector people are calling a bubble Mar 19 2015
    Coronado Biosciences Announces the Formation of Mustang Therapeutics, Inc. in Partnership with the... Mar 19 2015
    Coronado Biosciences Announces the Formation of Mustang Therapeutics, Inc. in Partnership With the... Mar 19 2015
    Coronado Biosciences Announces Exclusive Licensing Agreement with NeuPharma to Develop and... Mar 19 2015
    Coronado Biosciences Announces Exclusive Licensing Agreement With NeuPharma to Develop and... Mar 19 2015
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Mar 18 2015
    Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31,... Mar 16 2015
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 16 2015
    Coronado reports 4Q loss Mar 16 2015
    Coronado reports 4Q loss Mar 16 2015
    Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31,... Mar 16 2015
    TG Therapeutics-Coronado Sign Up Immuno-Oncology Deal - Analyst Blog Mar 06 2015
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Mar 05 2015
    Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology... Mar 04 2015
    TG Therapeutics Enters Into a Global Collaboration With Checkpoint Therapeutics to Develop and... Mar 04 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK